The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 06, 2023

Filed:

Aug. 02, 2018
Applicant:

Massachusetts Institute of Technology, Cambridge, MA (US);

Inventors:

David Lai, Philadelphia, PA (US);

Filippos Touriomousis, Cambridge, MA (US);

Andreas Mershin, Arlington, MA (US);

Neil Gershenfeld, Cambridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B01F 23/41 (2022.01); B01F 33/3011 (2022.01); C09D 11/102 (2014.01); A61K 9/107 (2006.01); B33Y 80/00 (2015.01); B01L 3/00 (2006.01); B01F 33/81 (2022.01); B01F 35/00 (2022.01); B01F 35/22 (2022.01); B01F 101/22 (2022.01);
U.S. Cl.
CPC ...
B01F 33/3011 (2022.01); A61K 9/107 (2013.01); B01F 23/41 (2022.01); B01F 33/813 (2022.01); B01F 35/2202 (2022.01); B01F 35/561 (2022.01); B01L 3/502784 (2013.01); B33Y 80/00 (2014.12); C09D 11/102 (2013.01); B01F 23/4143 (2022.01); B01F 2101/22 (2022.01); B01L 2300/0887 (2013.01);
Abstract

The invention comprises a novel modular, generalizable meso-micro-nano-fluidic platform apparatus, design and methodology which in exemplary embodiments may be applied in conjunction with a novel external triggering and automation/feedback loop control mechanism deployed via computer to explore the phase space of single or double emulsification for applications including the encapsulation of hydrophilic active pharmacological ingredients (APIs). End use applications include the mass production of particulate encapsulation of hydrophobic or hydrophilic APIs with automatic or user-supervised feedback methodology to control and discover mass production or per-drug customized settings of interest for the manufacture of novel or extant therapeutics. This invention allows for a process to produce monodispersed particles of varying sizes and may be used to rapidly screen for optimal size for maximal bioavailability of API particles either on lab bench for in vitro dissolution or in vivo studies, and patient-specific handhelds for maximal drug inhalation.


Find Patent Forward Citations

Loading…